top of page
THE
ARCHIVES
The FDA Just Changed the Testosterone Rulebook, What This Means To You
Just Happened On June 18, 2026 — during Men's Health Month — the U.S. Department of Health and Human Services (HHS), through the FDA, announced a request for class-wide updates to the prescribing information for all testosterone replacement therapy (TRT) products. These proposed changes represent the most significant regulatory revision to testosterone labeling since 2015 and signal a meaningful shift in how the U.S. government views the evidence base for TRT in aging men. HH
6 min read
bottom of page